Aller au contenu principal
Profil bibliographique

Sudharsan Sankar

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées
32Citations signalées
0Affiliations récentes

Les domaines associés

Microplastics and Plastic PollutionNeutropenia and Cancer InfectionsBlood disorders and treatmentsPhytochemicals and Antioxidant ActivitiesNanoparticles: synthesis and applications

Les publications récentes

2024 review OpenAlex

Zebrafish and Drosophila as Model Systems for Studying the Impact of Microplastics and Nanoplastics ‐ A Systematic Review

Sudharsan Sankar, Natarajan Chandrasekaran, Meivelu Moovendhan‬‬‬‬‬‬‬‬, Venkatachalam Deepa Parvathi

ABSTRACT Microplastics and nanoplastics (MNPs) are byproducts of plastics created to benefit humanity, but improper disposal and inadequate recycling have turned them into a global menace that we can no longer conceal. As they interact with all living organisms, including humans, their …

in (code pays fourni par la source)

10 citations Environmental Quality Management
Accès ouvert 2024 article OpenAlex

Flaxseed Oil, Casitose, and Its Combination Diets Increase Antioxidant Activity and Upregulates Aging-related Genes in Drosophila melanogaster

Indhuja Jayaraj, Vijaya Harini Sathyamurthy, Sudharsan Sankar, Selvaraj Ramasamy et autres

Abstract Background: Nutrigenomics refers to the study of how diet influences the genomic expression and function of an organism. Diet is a significant factor that impacts metabolism, aging, and lifespan. Long-term dietary patterns can influence the risk of age-related diseases, including diabetes, …

in (code pays fourni par la source)

1 citation Biomedical and Biotechnology Research Journal (BBRJ)
Accès ouvert 2009 article OpenAlex

Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony‐stimulating factor derivative Maxy‐G34 and pegfilgrastim in rats

Markus R. Scholz, Christoph Engel, Doris Apt, Sudharsan Sankar et autres

OBJECTIVES: This study aims to compare pharmacokinetics and pharmacodynamics of pegfilgrastim, a pharmaceutical recombinant human granulocyte colony-stimulating factor (rhG-CSF), with that of a newly developed reagent, Maxy-G34. This comparison was performed using rat experiments and biomathematical modelling of granulopoiesis. METHODS: Healthy rats …

us, de (code pays fourni par la source)

17 citations Cell Proliferation
2009 conference-abstract OpenAlex

An open-label, dose-escalating study of Maxy-G34, a novel potent, long-acting Pegylated G-CSF, compared with pegfilgrastim (PF) for the treatment of chemotherapy induced neutropenia (CIN)

L. S. Schwartzberg, Sudharsan Sankar, Doris Apt, E. J. C. Goldstein et autres

e14500 Background: rhG-CSF reduces the incidence and duration of CIN in patients (pts) receiving myelosuppressive chemotherapy. Maxy-G34 is a recombinant, modified human G-CSF, containing three 5 kD PEG groups. These modifications alter both renal and receptor mediated clearance, leading to a longer …

us, de (code pays fourni par la source)

4 citations Journal of Clinical Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.